← All companies
REGENERON PHARMACEUTICALS, INC.
REGN - CIK 0000872589
Market cap$56.80 B
Rank#292
SEC filings985
The table below shows REGENERON PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.12B | $2.49B | $2.73B | $3.11B | $2.89B | $2.19B |
| Short-term investments | $5.49B | $6.52B | $8.11B | $4.64B | $2.81B | $1.39B |
| Receivables | $5.74B | $6.21B | $5.67B | $5.33B | $6.04B | $3.11B |
| Inventory | $3.20B | $3.09B | $2.58B | $2.40B | $1.95B | $1.92B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.